Back to Journals » Drug Design, Development and Therapy » Volume 11

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Total article views   Abstract views HTML views PDF downloads Totals
9,701 Dovepress* 7,869 1,476+ 1,635 9,345
PubMed Central* 0 356 109 356
Totals 7,869 1,832 1,744 9,701
*Since 17 January 2017
+Since July 2016

View citations on PubMed Central and Google Scholar